Application 021918
- Type
- NDA
- Sponsor
- WRASER PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CETRAXAL | CIPROFLOXACIN HYDROCHLORIDE | SOLUTION/DROPS;OTIC | EQ 0.2% BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021918-001 | CETRAXAL | CIPROFLOXACIN HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS / OTIC | AB | RLD, RS | 2009-05-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021918-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021918-001 | CETRAXAL | EQ 0.2% BASE | SOLUTION/DROPS / OTIC | AB | RLD, RS | 2009-05-01 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021918-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 14c3bc33-201d-492e-9aee-a4d84c813a3d | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | HAWAII REPACK, INC. | 0fe3becb-f90e-4187-a8e8-bd0de5a79ad2 | 2026-07-13 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | a2ffa81a-86c5-40b9-8fa0-c889801ef479 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | a914512b-9a4a-4c53-ab7a-2e2b1ea8a012 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | Proficient Rx LP | b281a5c0-5f3e-4e6f-86ac-ed7794aac64c | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | 47d1e4c5-f669-4aca-9e8c-0d6bb833b859 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | Aurobindo Pharma Limited | 6a935846-3c97-4517-bc4e-2377f673285e | 2026-05-11 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | Redpharm Drug | 1ac4540c-d0f7-70bc-e063-6394a90a0f7a | 2026-05-05 | Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 4dd69fb7-802a-4278-a730-c722a3ca3521 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | d8b21832-b74f-4f85-a304-b907c9e01e72 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 9d83b127-ef13-4b2c-aa30-0f54937dc240 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | American Health Packaging | 275de35b-5c97-4ff8-a571-42e23c1cd83e | 2026-05-03 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | Asclemed USA, Inc. | ae77a5c0-a2ae-770c-e053-2a95a90a6a96 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 26e2d370-f59c-40ae-9c1e-7f8bf1f9fde4 | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | American Health Packaging | 0fac4466-fbe5-49d2-96e3-e3ac2739bd5b | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 78641acd-eedf-4b68-bb18-da0874415f59 | 2026-03-27 | Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| CIPROFLOXACIN | CIPROFLOXACIN HYDROCHLORIDE | DIRECT RX | a7e5174a-dd01-6050-e053-2a95a90add3f | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Cipro | CIPROFLOXACIN HYDROCHLORIDE | Bayer HealthCare Pharmaceuticals Inc. | 888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | Redpharm Drug | 4972e902-e042-e947-e063-6394a90a1b70 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 1057be77-00bb-4839-be3d-c8e11ae531a2 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42195-550 | Ciprofloxacin Otic | CIPROFLOXACIN | Xspire Pharma, Llc | NDA | Current |
| 42195-550 | Ciprofloxacin Otic | CIPROFLOXACIN | Xspire Pharma | NDA | Current |
| 42195-550 | Ciprofloxacin Otic | CIPROFLOXACIN | Xspire Pharma | NDA | Current |
| 66992-450 | CETRAXAL | Ciprofloxacin | Wraser Llc | NDA | Current |
| 66992-450 | CETRAXAL | Ciprofloxacin | Wraser Llc | NDA | Current |